✦ LIBER ✦

25: Benefits and risks of weight loss medications: Evidence from meta-analyses

Book ID: 119287225
Publisher: Elsevier
Year: 2008
Tongue: English
Weight: 79 KB
Volume: 2
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2008.08.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What are the risks and the benefits of c

What are the risks and the benefits of current and emerging weight-loss medications?

✍ Jamie R. Robinson; Kevin D. Niswender 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 310 KB

The Cys allele of the DRD2 Ser311Cys pol

The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: Evidence from fixed- and random-effects meta-analyses

✍ Stephen J. Glatt; Erik G. Jönsson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## Abstract Previously we derived independent estimates of the effect of the dopamine D2 receptor (__DRD2__) Ser311Cys polymorphism on risk for schizophrenia using fixed‐ and random‐effects meta‐analyses. Both analyses identified a significant association between the Cys allele and schizophrenia, b

Self-efficacy for temptations is a bette

Self-efficacy for temptations is a better predictor of weight loss than motivation and global self-efficacy: Evidence from two prospective studies among overweight/obese women at high risk of breast cancer

✍ Armitage, Christopher J.; Wright, Claire L.; Parfitt, Gaynor; Pegington, Mary; D 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 298 KB